GM-CSF: intravenous versus subcutaneous treatment.
Aglietta
M
M
Clinica Medica A, Universitá di Torino, Italy.
Monzeglio
C
C
Piacibello
W
W
Aprá
F
F
Stacchini
A
A
Sanavio
F
F
Mossetti
C
C
Stern
A C
AC
Gavosto
F
F
D003115:Colony-Stimulating Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D004341:Drug Evaluation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007962:Leukocytes / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor